Jacobi Capital Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$2K | – | 1456 |
|
|
2021
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1357 |
|
|
2021
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1299 |
|
|
2021
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1276 |
|
|
2020
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1196 |
|
|
2020
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1065 |
|
|
2020
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 973 |
|
|
2020
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1122 |
|
|
2019
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1058 |
|
|
2019
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1039 |
|
|
2019
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1030 |
|
|
2019
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 873 |
|
|
2018
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 884 |
|
|
2018
Q3 | $5K | Sell |
1,000
-7
| -0.7% | -$35 | ﹤0.01% | 805 |
|
|
2018
Q2 | $5K | Hold |
1,007
| – | – | ﹤0.01% | 841 |
|
|
2018
Q1 | $7K | Hold |
1,007
| – | – | ﹤0.01% | 762 |
|
|
2017
Q4 | $8K | Hold |
1,007
| – | – | ﹤0.01% | 714 |
|
|
2017
Q3 | $9K | Hold |
1,007
| – | – | ﹤0.01% | 662 |
|
|
2017
Q2 | $10K | Buy |
1,007
+7
| +0.7% | +$70 | ﹤0.01% | 581 |
|
|
2017
Q1 | $10K | Buy |
1,000
+500
| +100% | +$5K | 0.01% | 471 |
|
|
2016
Q4 | $6K | Sell |
500
-500
| -50% | -$6K | ﹤0.01% | 489 |
|
|
2016
Q3 | $17K | Hold |
1,000
| – | – | 0.01% | 394 |
|
|
2016
Q2 | $10K | Buy |
+1,000
| New | +$10K | 0.01% | 463 |
|